{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Paul+Farrelly&max-ddpModified.=2019-07-11T16%3A49%3A49.406Z&published=true&answer.answeringMemberPrinted=Seema+Kennedy&max-answer.questionFirstAnswered.=2019-07-16T16%3A07%3A23.213Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMember.label=Biography+information+for+Paul+Farrelly&max-ddpModified.=2019-07-11T16%3A49%3A49.406Z&published=true&answer.answeringMemberPrinted=Seema+Kennedy&max-answer.questionFirstAnswered.=2019-07-16T16%3A07%3A23.213Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Paul+Farrelly&max-ddpModified.=2019-07-11T16%3A49%3A49.406Z&published=true&_metadata=all&answer.answeringMemberPrinted=Seema+Kennedy&max-answer.questionFirstAnswered.=2019-07-16T16%3A07%3A23.213Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Paul+Farrelly&_page=0&max-ddpModified.=2019-07-11T16%3A49%3A49.406Z&published=true&answer.answeringMemberPrinted=Seema+Kennedy&max-answer.questionFirstAnswered.=2019-07-16T16%3A07%3A23.213Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Paul+Farrelly&max-ddpModified.=2019-07-11T16%3A49%3A49.406Z&published=true&answer.answeringMemberPrinted=Seema+Kennedy&max-answer.questionFirstAnswered.=2019-07-16T16%3A07%3A23.213Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Paul+Farrelly&max-ddpModified.=2019-07-11T16%3A49%3A49.406Z&published=true&answer.answeringMemberPrinted=Seema+Kennedy&max-answer.questionFirstAnswered.=2019-07-16T16%3A07%3A23.213Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1138491", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1138491/answer", "answerText" : {"_value" : "
No such assessment has been made. The Government keeps evidence on tobacco control under review. Decisions on the best licensed smoking cessation support to prescribe are a matter for clinicians in discussion with their patients, taking account of guidance including advice published by the National Institute for Health and Care Excellence.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-16T14:34:30.307Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Smoking: Mental Illness"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of implications for his policies of the recent study published in the journal, Nicotine & Tobacco Research entitled, Prescribing prevalence, effectiveness, and mental health safety of smoking cessation medicines in patients with mental disorders.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1436", "label" : {"_value" : "Biography information for Paul Farrelly"} } , "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"} , "tablingMemberPrinted" : [{"_value" : "Paul Farrelly"} ], "uin" : "276169"} , {"_about" : "http://data.parliament.uk/resources/1137781", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137781/answer", "answerText" : {"_value" : "
The NHS Long Term Plan outlines NHS England and NHS Improvement\u2019s commitment to improve the prevention, early detection and treatment of cardiovascular disease. As part of this, local systems will work to better support people with heart failure and heart valve disease through multi-disciplinary teams as part of primary care networks.<\/p>
To improve early detection of heart failure, pilot schemes will be established in 2020/21 and 2021/22 to increase access to echocardiography, ahead of a wider rollout. Greater access to echocardiography in primary care will improve the investigation of those with breathlessness, and the early detection of heart failure and valve disease.<\/p>
There are published service specifications that promote network working to ensure cardiac pathways are well-defined.<\/p>
The Specialised Commissioning Cardiac Improvement Programme is also focusing on improving multi-disciplinary team working, including the use of technology to optimise the available resource within clinical teams.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-15T16:42:16.183Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Heart Diseases: Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the National Implementation Framework of the NHS Long Term Plan facilitates delivery of (a) improved equity in access to treatment for heart valve disease, (b) additional funding for treatment of heart valve disease to enable healthy ageing and (c) increased NHS capacity for multidisciplinary teams providing care to all heart valve disease patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1436", "label" : {"_value" : "Biography information for Paul Farrelly"} } , "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"} , "tablingMemberPrinted" : [{"_value" : "Paul Farrelly"} ], "uin" : "275132"} , {"_about" : "http://data.parliament.uk/resources/1136522", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1136522/answer", "answerText" : {"_value" : "
The NHS England Specialised Cardiac Improvement Programme is working to streamline pathways for patients so they can access specialist teams able to offer advice on the full range of treatment options supported by evidence of effectiveness and long term patient outcomes.<\/p>
NHS England Specialised Commissioning considers it is important that patients are aware of all treatment options and this includes access to less invasive treatments, where clinically appropriate. NHS England is currently considering less invasive interventions for structural heart disease as part of its 2019/20 clinical policy pipeline.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-08T16:15:57.027Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Heart Diseases: Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure equitable access to less invasive treatments for structural heart diseases throughout the regions of England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1436", "label" : {"_value" : "Biography information for Paul Farrelly"} } , "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"} , "tablingMemberPrinted" : [{"_value" : "Paul Farrelly"} ], "uin" : "272771"} , {"_about" : "http://data.parliament.uk/resources/1136297", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1136297/answer", "answerText" : {"_value" : "
No such assessment has been made. The European Union Tobacco Products Directive (TPD) sets the maximum nicotine emission level at one milligram of nicotine per cigarette. The United Kingdom transposed the TPD through the Tobacco and Related Products Regulations 2016 (TRPR), which came into force on 20 May 2016.<\/p>
The Government will meet its obligation to review the TRPR before 20 May 2021 and will also review where the UK\u2019s exit from the EU offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation\u2019s health.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-08T15:40:00.06Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Tobacco"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of encouraging manufacturers to reduce levels of nicotine in all cigarettes to reduce dependency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1436", "label" : {"_value" : "Biography information for Paul Farrelly"} } , "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"} , "tablingMemberPrinted" : [{"_value" : "Paul Farrelly"} ], "uin" : "272151"} , {"_about" : "http://data.parliament.uk/resources/1136401", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1136401/answer", "answerText" : {"_value" : "
The Government recognises the profound impact that sight loss can have on a person\u2019s life and the important and valuable role that Eye Clinic Liaison Officers can play in supporting patients at the point of diagnosis of sight loss and beyond. For those newly diagnosed with sight loss, access to information about appropriate support and rehabilitation services is vital.<\/p>
Clinical commissioning groups are responsible for commissioning all secondary care ophthalmology services, including eye clinics and their staffing. Decisions on the provision of services that meet the needs of their local population should be made locally, rather than at a national level.<\/p>
NHS England and NHS Improvement have advised that Royal Stoke University Hospital currently employs two part-time members of staff to deliver the Eye Clinical Liaison Officer role.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-08T16:08:38.063Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Ophthalmic Services: Staff"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he plans to have eye clinic liaison officers deployed at (a) Royal Stoke University Hospital and (b) all hospitals in England with ophthalmology departments.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1436", "label" : {"_value" : "Biography information for Paul Farrelly"} } , "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"} , "tablingMemberPrinted" : [{"_value" : "Paul Farrelly"} ], "uin" : "272161"} , {"_about" : "http://data.parliament.uk/resources/1136403", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1136403/answer", "answerText" : {"_value" : "
The United Kingdom National Screening Committee (UK NSC) has not formally reviewed the evidence for a national screening programme for structural heart disease. However, the UK NSC welcomes new topic proposals through its annual call for topics from September to December each year. Information on how to submit a new proposal can be found at the following link:<\/p>